View in EDS

Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial.
Authors: Hassan R; Thoracic and GI Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Thomas A; Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Nemunaitis JJ; Division of Hematology and Oncology, University of Toledo College of Medicine, Toledo, Ohio., Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota., Bennouna J; Department of Pneumology, Thoracic Oncology Unit, University Hospital of Nantes, Nantes, France., Chen FL; Novant Health Oncology Specialists, Winston-Salem, North Carolina., Delord JP; Institut Universitaire du Cancer-Oncopole, Toulouse, France., Dowlati A; Division of Hematology and Oncology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio., Kochuparambil ST; Virginia Piper Cancer Institute, Minneapolis, Minnesota., Taylor MH; Knight Cancer Institute, Oregon Health & Science University, Portland., Powderly JD; Carolina BioOncology Institute, Huntersville, North Carolina., Vaishampayan UN; Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Verschraegen C; Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus., Grote HJ; Merck KGaA, Darmstadt, Germany., von Heydebreck A; Merck KGaA, Darmstadt, Germany., Chin K; EMD Serono, Billerica, Massachusetts., Gulley JL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Source: JAMA oncology [JAMA Oncol] 2019 Mar 01; Vol. 5 (3), pp. 351-357.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30605211
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hassan+R%22">Hassan R</searchLink>; Thoracic and GI Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Thomas+A%22">Thomas A</searchLink>; Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Nemunaitis+JJ%22">Nemunaitis JJ</searchLink>; Division of Hematology and Oncology, University of Toledo College of Medicine, Toledo, Ohio.<br /><searchLink fieldCode="AU" term="%22Patel+MR%22">Patel MR</searchLink>; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota.<br /><searchLink fieldCode="AU" term="%22Bennouna+J%22">Bennouna J</searchLink>; Department of Pneumology, Thoracic Oncology Unit, University Hospital of Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Chen+FL%22">Chen FL</searchLink>; Novant Health Oncology Specialists, Winston-Salem, North Carolina.<br /><searchLink fieldCode="AU" term="%22Delord+JP%22">Delord JP</searchLink>; Institut Universitaire du Cancer-Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Dowlati+A%22">Dowlati A</searchLink>; Division of Hematology and Oncology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Kochuparambil+ST%22">Kochuparambil ST</searchLink>; Virginia Piper Cancer Institute, Minneapolis, Minnesota.<br /><searchLink fieldCode="AU" term="%22Taylor+MH%22">Taylor MH</searchLink>; Knight Cancer Institute, Oregon Health & Science University, Portland.<br /><searchLink fieldCode="AU" term="%22Powderly+JD%22">Powderly JD</searchLink>; Carolina BioOncology Institute, Huntersville, North Carolina.<br /><searchLink fieldCode="AU" term="%22Vaishampayan+UN%22">Vaishampayan UN</searchLink>; Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.<br /><searchLink fieldCode="AU" term="%22Verschraegen+C%22">Verschraegen C</searchLink>; Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus.<br /><searchLink fieldCode="AU" term="%22Grote+HJ%22">Grote HJ</searchLink>; Merck KGaA, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22von+Heydebreck+A%22">von Heydebreck A</searchLink>; Merck KGaA, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Chin+K%22">Chin K</searchLink>; EMD Serono, Billerica, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Gulley+JL%22">Gulley JL</searchLink>; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101652861%22">JAMA oncology</searchLink> [JAMA Oncol] 2019 Mar 01; Vol. 5 (3), pp. 351-357.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101652861 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-2445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223742437%22">23742437 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30605211
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamaoncol.2018.5428
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 351
    Titles:
      – TitleFull: Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hassan R
      – PersonEntity:
          Name:
            NameFull: Thomas A
      – PersonEntity:
          Name:
            NameFull: Nemunaitis JJ
      – PersonEntity:
          Name:
            NameFull: Patel MR
      – PersonEntity:
          Name:
            NameFull: Bennouna J
      – PersonEntity:
          Name:
            NameFull: Chen FL
      – PersonEntity:
          Name:
            NameFull: Delord JP
      – PersonEntity:
          Name:
            NameFull: Dowlati A
      – PersonEntity:
          Name:
            NameFull: Kochuparambil ST
      – PersonEntity:
          Name:
            NameFull: Taylor MH
      – PersonEntity:
          Name:
            NameFull: Powderly JD
      – PersonEntity:
          Name:
            NameFull: Vaishampayan UN
      – PersonEntity:
          Name:
            NameFull: Verschraegen C
      – PersonEntity:
          Name:
            NameFull: Grote HJ
      – PersonEntity:
          Name:
            NameFull: von Heydebreck A
      – PersonEntity:
          Name:
            NameFull: Chin K
      – PersonEntity:
          Name:
            NameFull: Gulley JL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2019 Mar 01
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 2374-2445
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: JAMA oncology
              Type: main
ResultId 1